Related references
Note: Only part of the references are listed.The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome
Sandro Goruppi et al.
NATURE COMMUNICATIONS (2023)
Prenatal exposure to nitrofurantoin and risk of childhood leukaemia: a registry-based cohort study in four Nordic countries
Sarah Hjorth et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)
Protein disulfide isomerase A1-associated pathways in the development of stratified breast cancer therapies
Emyr Yosef Bakker et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2022)
Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers
Carlos A. Barron-Gallardo et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)
Tau in the Pathophysiology of Parkinson's Disease
Lina Pan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Large-scale integration of the plasma proteome with genetics and disease
Egil Ferkingstad et al.
NATURE GENETICS (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Liam Gaziano et al.
NATURE MEDICINE (2021)
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Urmo Vosa et al.
NATURE GENETICS (2021)
Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
Masanori Kurihara et al.
BRAIN SCIENCES (2020)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Haoyu Zhan et al.
NATURE GENETICS (2020)
MDM2 inhibition: an important step forward in cancer therapy
Marina Konopleva et al.
LEUKEMIA (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer
Stephanie Papin et al.
BRAIN SCIENCES (2020)
BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
Anbok Lee et al.
ANNALS OF LABORATORY MEDICINE (2020)
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Kevin H. Strang et al.
LABORATORY INVESTIGATION (2019)
Medication Use for the Risk Reduction of Primary Breast Cancer in Women Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Heidi D. Nelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement
Douglas K. Owens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5
Xiaojie Yu et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression
Jorge Baquero et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
Lukas Lofling et al.
CLINICAL EPIDEMIOLOGY (2019)
Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study
Jesper Hallas et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits
Yang Wu et al.
NATURE COMMUNICATIONS (2018)
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
Andrea V. Margulis et al.
PLOS ONE (2018)
Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
Babak Nami et al.
CANCERS (2018)
Identification of 55,000 Replicated DNA Methylation QTL
Allan F. McRae et al.
SCIENTIFIC REPORTS (2018)
Risk Factors and Preventions of Breast Cancer
Yi-Sheng Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Palmitoylation-dependent activation of MC1R prevents melanomagenesis
Shuyang Chen et al.
NATURE (2017)
Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias
James A. Kaye et al.
PHARMACOTHERAPY (2017)
Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease
Tatsuo Mano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The druggable genome and support for target identification and validation in drug development
Chris Finan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Exposure to systemic antibacterial medications during pregnancy and risk of childhood cancer
Natalie C. Momen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
S. Nag et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry
Jianguang Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
Hirokuni Ikeda et al.
BREAST CANCER RESEARCH (2010)
Autophagy mediates the mitotic senescence transition
Andrew R. J. Young et al.
GENES & DEVELOPMENT (2009)
Raloxifene in breast cancer prevention
Luigi Gennari et al.
EXPERT OPINION ON DRUG SAFETY (2008)
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity
Paola Di Stefano et al.
EMBO JOURNAL (2007)
Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk
Kari Hemminki et al.
CANCER RESEARCH (2007)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Antibiotics and the risk of breast cancer
JA Kaye et al.
EPIDEMIOLOGY (2005)
Share Paper
